Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants
Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19

Showing 19 citing articles:

A Brief Review on Dna Vaccines in the Era of COVID-19
Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, et al.
Future Virology (2021) Vol. 17, Iss. 1, pp. 49-66
Open Access | Times Cited: 91
Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
Ami Patel, Jewell Walters, Emma L. Reuschel, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100420-100420
Open Access | Times Cited: 51
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure
Mammen P. Mammen, Pablo Tebas, Joseph Agnes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
Simone Lanini, Stefania Capone, Andrea Antinori, et al.
Science Translational Medicine (2021) Vol. 14, Iss. 627
Open Access | Times Cited: 26
COVID-19 vaccines: Update of the vaccines in use and under development
Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, et al.
Vacunas (2022) Vol. 23, pp. S88-S102
Open Access | Times Cited: 15
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
Ali Salimi Jeda, Sina Abbassi, Atieh Mousavizadeh, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108232-108232
Open Access | Times Cited: 18
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model
Karen E. Gooch, Trevor R.F. Smith, Francisco J. Salguero, et al.
Vaccine (2021) Vol. 39, Iss. 34, pp. 4885-4894
Open Access | Times Cited: 17
Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases
Shalini Iyer, Rajesh Yadav, Smriti Agarwal, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 14
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
Jewell Walters, Blake Schouest, Ami Patel, et al.
Vaccine (2022) Vol. 40, Iss. 21, pp. 2960-2969
Open Access | Times Cited: 10
Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets
Shane Riddell, Sarah Goldie, Alexander J. McAuley, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 10
Innovative vaccine approaches—a Keystone Symposia report
Jennifer Cable, Rino Rappuoli, Elizabeth J. Klemm, et al.
Annals of the New York Academy of Sciences (2022) Vol. 1511, Iss. 1, pp. 59-86
Open Access | Times Cited: 6
Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine
Charles C. Reed, Katherine Schultheis, Viviane M. Andrade, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 7
Biopharmaceuticals for prevention of COVID-19
Afsaneh Farjami, Soheila Montazersaheb, Saiedeh Razi Soofiyani, et al.
Asian Pacific Journal of Tropical Medicine (2022) Vol. 15, Iss. 6, pp. 245-265
Open Access | Times Cited: 4
Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets
Shane Riddell, Sarah Goldie, Alexander J. McAuley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Safety and immunogenicity of a recombinant DNA COVID-19 vaccine containing the coding regions of the spike and nucleocapsid proteins: Preliminary results from an open-label, phase 1 trial in healthy adults aged 19–55 years
Jin Young Ahn, Jeongsoo Lee, You Suk Suh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
Jewell Walters, Blake Schouest, Ami Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
COVID-19 vaccines: Update of the vaccines in use and under development
Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, et al.
Vacunas (English Edition) (2022) Vol. 23, pp. S88-S102
Closed Access
SARS-COV-2. Origen, vacunas, variantes y el futuro de la pandemia
Adriana Delfraro
Revista Educación en Ciencias Biológicas (2021) Vol. 6, Iss. 1
Open Access
Page 1

Scroll to top